DABUS: South Africa issues first-ever patent with AI inventor

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

DABUS: South Africa issues first-ever patent with AI inventor

artificial-intelligence-min-final.jpg

Despite the world first, South Africa’s IP office does not formally examine patents – so the registration could yet be opposed

South Africa has become the first country to issue a patent designating an artificial intelligence tool – DABUS – as the inventor and the machine’s owner as the patent owner.

The patent was published in South Africa’s Patent Journal yesterday, July 28, with legal representatives Ryan Abbott and Von Seidels both confirming the news.

However, South Africa does not offer formal examination and instead requires applicants to merely complete a filing for their invention. The same patent has already been rejected in the UK, the US and at the EPO.

Related stories

The invention was generated by DABUS (Device for the Autonomous Bootstrapping of Unified Sentience), which was created by Stephen Thaler, CEO of Imagination Engines. He has now been listed as the owner of the patent in South Africa.

In an interview with Managing IP, Thaler described DABUS as human-like, saying it is “sentient and develops ideas”. DABUS-created inventions include an emergency warning light and a food container that improves grip and heat transfer.

With the patent now officially granted by the Companies and Intellectual Property Commission, South Africa’s IP office, it is open to objection based on novelty and inventiveness.

Abbott – who has led a group of attorneys on behalf of DABUS and Thaler – hailed it as a crucial development in AI.

“We see this issuance as a key step towards recognition of the importance of encouraging individuals and companies to make, develop and use AI to generate socially valuable innovations.

“As AI continues to advance and to increasingly perform human sorts of activities, this will result in a host of challenges and opportunities for businesses, including with respect to disputes.”

The patent is the subject of parallel pending proceedings including in the US, UK, Germany, Australia and at the EPO.

Abbott himself argued in one of the cases this week at the England and Wales Court of Appeal, which is hearing the case after the High Court upheld a UKIPO ruling that DABUS could not be deemed the inventor of the patent.

more from across site and SHARED ros bottom lb

More from across our site

Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Firms with established sports relationships and specialised expertise are well positioned to capture the market’s expanded pool of IP work
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia
Wins in court have been key to the six-year-old firm’s growth, as one of its founders explains
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
Aditi Verma Thakur, managing partner at Aishani Partners, discusses 5 am wake-ups, working with high-performing professionals and staying calm under pressure
After more than three decades at Wilson Sonsini, Ian Edvalson explains why he moved to expand his life sciences transactional practice
Gift this article